Anne Jordan was diagnosed with blood cancer in 2016. After multiple treatments of chemotherapy and radiation, her doctors recommended she consult Dr. Nakhle Saba, director of the CAR-T program at Our Lady of the Lake Cancer Institute in Baton Rouge.
In March, Jordan became the first patient in the region to receive CAR-T cell therapy in an outpatient setting — a milestone for the Lake and for blood cancer patients across Louisiana.
CAR-T cell therapy, or Chimeric Antigen Receptor T-cell therapy, is an FDA-approved treatment for certain blood cancers that re-engineers a patient’s own immune cells to identify and attack cancer…